Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal

Fig. 5

Biosafety in vivo of UCMS@Pep-aPDL1. A Results of routine blood count in mice treated with PBS and UCMS@Pep-aPDL1 (n ≥ 3); B Biochemistry indexes in mice treated with PBS and UCMS@Pep-aPDL1 (n ≥ 3); C H&E staining results obtained for the major organs of mice subjected to different treatments (Scale bar = 100 μm)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us